JohnTysonVettoMD
General Surgery • Portland, ORSurgical Oncology (Other than Breast)
Associate Professor of Surgery, Oregon Hlth & Sci Univ
Dr. Vetto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5501
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1984 - 1989
Brigham and Women's HospitalResidency, Surgery, 1982 - 1984
Oregon Health and Science University School of MedicineClass of 1982
Certifications & Licensure
OR State Medical License 1991 - 2025- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Start of enrollment: 2000 Aug 01
- OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer Start of enrollment: 2005 Apr 01
Publications & Presentations
PubMed
- 51 citationsGuidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.John T. Vetto, Eddy C. Hsueh, Brian R. Gastman, Larry D Dillon, Federico A Monzon
Future Oncology. 2019-01-29 - 69 citationsFactors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter DatabaseRichard L. White, Gregory D. Ayers, Virginia H. Stell, Shouluan Ding, Jeffrey E. Gershenwald
Annals of Surgical Oncology. 2011-06-07 - 8 citationsRegression is significantly associated with outcomes for patients with melanoma.Sarayu Subramanian, Gang Han, Natalie Olson, Stanley P. L. Leong, Mohammed Kashani-Sabet
Surgery. 2021-06-11
Journal Articles
- Microsatellitosis in Patients with MelanomaRichard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Dale Han, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, ..., Annals of Surgical Oncology
Press Mentions
Castle Biosciences Announces Publication of Prospective Multicenter Study Demonstrating That Its DecisionDx-Melanoma Test Can Inform Sentinel Lymph Node Biopsy DecisionsJanuary 30th, 2019- Castle Biosciences’ DecisionDx-Melanoma Test Identifies High-Risk Melanoma Patients Among Those Traditionally Staged as Low Risk in Newly Published StudyJanuary 7th, 2019
- Independent Study Demonstrates Significant and Risk-Appropriate Clinical Impact of DecisionDx-Melanoma Test Results on Patient Management Decisions in MelanomaMarch 21st, 2018
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
